Showing results (1141-1150 of 22,814) with videos related to
Sort By:
Pageof 2,282
Preventive Veterinary Medicine|February 27, 2017
Epidemiological investigation of bovine tuberculosis outbreaks in Uruguay (2011-2013)Catalina Picasso, Julio Alvarez, Kimberly L VanderWaal, et al.Environmental Health Perspectives|January 31, 2015
Arsenic exposure and prevalence of the varicella zoster virus in the United States: NHANES (2003-2004 and 2009-2010)Andres Cardenas, Ellen Smit, E Andres Houseman, et al.European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|October 23, 2012
Solid-state dependent dissolution and oral bioavailability of piroxicam in ratsAndres Lust, Ivo Laidmäe, Mirja Palo, et al.European Journal of Obstetrics, Gynecology, and Reproductive Biology|August 6, 2010
Genetic variations in vascular endothelial growth factor but not in angiotensin I-converting enzyme genes are associated with endometriosis in Estonian womenMerit Lamp, Merli Saare, Triin Laisk, et al.Drug Development and Industrial Pharmacy|March 10, 2017
Development of electrosprayed artesunate-loaded core-shell nanoparticlesHoang Nhan Ho, Ivo Laidmäe, Karin Kogermann, et al.Journal of Child Neurology|July 5, 2007
Neonatal spinal muscular atrophy type 1 with bone fractures and heart defectEve Vaidla, Inga Talvik, Andres Kulla, et al.The Application of Clinical Genetics|September 18, 2020
Hutchinson-Gilford Progeria Syndrome: Clinical and Molecular CharacterizationHarry Pachajoa, Angelica Claros-Hulbert, Ximena García-Quintero, et al.Journal of Molecular and Cellular Cardiology|November 26, 2009
Substantially altered expression pattern of cannabinoid receptor 2 and activated endocannabinoid system in patients with severe heart failureFlorian Weis, Andres Beiras-Fernandez, Ralf Sodian, et al.Peptides|September 1, 2010
Altered myocardial expression of ghrelin and its receptor (GHSR-1a) in patients with severe heart failureAndres Beiras-Fernandez, Simone Kreth, Florian Weis, et al.Targeted Oncology|September 13, 2012
Targeting ALK: a promising strategy for the treatment of non-small cell lung cancer, non-Hodgkin's lymphoma, and neuroblastomaAndres Morales La Madrid, Andres Morales La Madrid, Nicholas Campbell, et al.Pageof 2,282